Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

BACKGROUND: Evidence suggests that both selective cyclooxygenase (COX)‐2 inhibitors and non‐selective non‐steroidal anti‐inflammatory drugs (NSAIDs) increase the risk of cardiovascular events. However, evidence from prospective studies of currently available COX‐2 inhibitors and non‐selective NSAIDs...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Farkouh, M E, Greenberg, J D, Jeger, R V, Ramanathan, K, Verheugt, F W A, Chesebro, J H, Kirshner, H, Hochman, J S, Lay, C L, Ruland, S, Mellein, B, Matchaba, P T, Fuster, V, Abramson, S B
格式: Artigo
語言:Inglês
出版: BMJ Group 2007
主題:
Extended Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1954641/
https://ncbi.nlm.nih.gov/pubmed/17412741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.066001
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍